Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of selling price gouging, pointing out the stark distinction among U.S. price ranges and those in Europe and copyright.California biotech behemoth Amgen ditched options for an experimental weight loss capsule in